 |
Previous Article | Next Article 
Volume 17, Number 13,
Issue of July 1, 1997
pp. 4994-5003
Copyright ©1997 Society for Neuroscience
Cholecystokinin Increases GABA Release by Inhibiting a Resting
K+ Conductance in Hippocampal Interneurons
Received March 12, 1997; revised April 14, 1997; accepted April 16, 1997.
Karen K. Miller1,
Alan Hoffer1,
Kurt R. Svoboda1, and
Carl R. Lupica1, 2
1 Department of Pharmacology and 2 Program
in Neuroscience, University of Colorado Health Sciences Center, Denver,
Colorado 80262
Cholecystokinin (CCK) is found co-localized with the inhibitory
neurotransmitter GABA in interneurons of the hippocampus. Also, CCK
receptors are found in abundance in this brain region. The possibility
that CCK alters interneuron activity was examined using whole-cell
current- and voltage-clamp recordings from visualized interneurons in
the stratum radiatum of area CA1 in rat hippocampal slices. The effect
of CCK on GABA-mediated IPSCs was also determined in pyramidal neurons.
The sulfated octapeptide CCK-8S increased action potential frequency or
generated inward currents in the majority of interneurons. These
effects of CCK persisted in the presence of tetrodotoxin and cadmium,
suggesting that they were direct. Current-voltage plots revealed that
CCK-8S inhibited a conductance that was linear across command
potentials and reversed near the equilibrium potential for
K+ ions. The K+ channel blocker
tetraethylammonium (10 mM) generated inward currents similar to those initiated by CCK, and it occluded the effect of the
peptide. BaCl2 (1 mM) and 4-aminopyridine (2 mM) did not alter the effect of CCK. The CCKB
receptor antagonist PD-135,158 completely blocked the inward currents
generated by CCK-8S. CCK also resulted in an increase in spontaneous
action potential-dependent IPSC frequency, but no changes in action
potential-independent miniature IPSCs or evoked IPSCs in pyramidal
neurons. These results provide evidence that CCK can depolarize
hippocampal interneurons through the inhibition of a resting
K+ conductance, leading to increased tonic
inhibition of pyramidal neurons. This action of CCK may contribute to
its anticonvulsant properties, as observed in limbic seizure
models.
Key words:
electrophysiology;
epilepsy;
hippocampus;
leak
conductance;
neuropeptides;
potassium channel
This article has been cited by other articles:

|
 |

|
 |
 
M. Oz, K.-H. Yang, T. S. Shippenberg, L. P. Renaud, and M. J. O'Donovan
Cholecystokinin B-Type Receptors Mediate a G-Protein-Dependent Depolarizing Action of Sulphated Cholecystokinin Ocatapeptide (CCK-8s) on Rodent Neonatal Spinal Ventral Horn Neurons
J Neurophysiol,
September 1, 2007;
98(3):
1108 - 1114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-Y. Deng, J. E. Porter, H.-S. Shin, and S. Lei
Thyrotropin-releasing hormone increases GABA release in rat hippocampus
J. Physiol.,
December 1, 2006;
577(2):
497 - 511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-Y. Deng and S. Lei
Bidirectional modulation of GABAergic transmission by cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats
J. Physiol.,
April 15, 2006;
572(2):
425 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Lupica, J. A. Bell, A. F. Hoffman, and P. L. Watson
Contribution of the Hyperpolarization-Activated Current (Ih) to Membrane Potential and GABA Release in Hippocampal Interneurons
J Neurophysiol,
July 1, 2001;
86(1):
261 - 268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Hoffman and C. R. Lupica
Direct Actions of Cannabinoids on Synaptic Transmission in the Nucleus Accumbens: A Comparison With Opioids
J Neurophysiol,
January 1, 2001;
85(1):
72 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Heinricher, S. McGaraughty, and V. Tortorici
Circuitry Underlying Antiopioid Actions of Cholecystokinin Within the Rostral Ventromedial Medulla
J Neurophysiol,
January 1, 2001;
85(1):
280 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Hoffman and C. R. Lupica
Mechanisms of Cannabinoid Inhibition of GABAA Synaptic Transmission in the Hippocampus
J. Neurosci.,
April 1, 2000;
20(7):
2470 - 2479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sebret, I. Lena, D. Crete, T. Matsui, B. P. Roques, and V. Dauge
Rat Hippocampal Neurons Are Critically Involved in Physiological Improvement of Memory Processes Induced by Cholecystokinin-B Receptor Stimulation
J. Neurosci.,
August 15, 1999;
19(16):
7230 - 7237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Svoboda, C. E. Adams, and C. R. Lupica
Opioid Receptor Subtype Expression Defines Morphologically Distinct Classes of Hippocampal Interneurons
J. Neurosci.,
January 1, 1999;
19(1):
85 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Svoboda and C. R. Lupica
Opioid Inhibition of Hippocampal Interneurons via Modulation of Potassium and Hyperpolarization-Activated Cation (Ih) Currents
J. Neurosci.,
September 15, 1998;
18(18):
7084 - 7098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Aradi and I. Soltesz
Modulation of network behaviour by changes in variance in interneuronal properties
J. Physiol.,
January 1, 2002;
538(1):
227 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|